Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Syndicate
Context Therapeutics 1.5M share IPO price range $12.00-$14.00 » 12:09
07/13/21
07/13
12:09
07/13/21
12:09
CNTX

Context Therapeutics

/

+

ThinkEquity is acting as…

ThinkEquity is acting as sole book running manager for the offering.

Over a quarter ago
Hot Stocks
Centrexion raises $40.5M, adds Lilly, Exome asset Management as investors » 08:11
10/29/20
10/29
08:11
10/29/20
08:11
CNTX

Context Therapeutics

$0.00 /

+ (+0.00%)

, LLY

Eli Lilly

$131.30 /

-0.63 (-0.48%)

Centrexion Therapeutics…

Centrexion Therapeutics (CNTX) announced that it has raised $40.5 million of cash via: Convertible security investments from Lilly (LLY) and Exome Asset Management - each a new investor in Centrexion; Collaboration-related investment from Lilly which signifies continued confidence in our joint compound; and Expanded lending from the existing debt facility with Solar Capital Partners, LLC. Inclusive of this $40.5 million raise, Centrexion has in excess of $75 million of cash to deploy for the continued in-licensing of drug candidates and development of its portfolio of four clinical-stage drug candidates including: 4975 in Phase 3 for knee osteoarthritis pain; 6970 in Phase 2a for osteoarthritis pain; 6016 in Phase 1b/2a for diabetic neuropathy; 0290 in Phase 2a for neuropathic, musculoskeletal and inflammatory pain. In addition to the drug candidates listed above, Centrexion expects to close within the next few months on the acquisition of another mid-development stage drug candidate addressing pain.

ShowHide Related Items >><<
LLY Eli Lilly
$131.30 /

-0.63 (-0.48%)

CNTX Context Therapeutics
$0.00 /

+ (+0.00%)

LLY Eli Lilly
$131.30 /

-0.63 (-0.48%)

10/27/20 Benchmark
Lilly stop may 'hint' at similar results for Regeneron cocktail, says Benchmark
10/23/20
Fly Intel: Pre-market Movers
10/23/20 Truist
Eli Lilly initiated with a Buy at Truist
10/16/20 JPMorgan
Eli Lilly price target raised to $200 from $190 at JPMorgan
LLY Eli Lilly
$131.30 /

-0.63 (-0.48%)

LLY Eli Lilly
$131.30 /

-0.63 (-0.48%)

LLY Eli Lilly
$131.30 /

-0.63 (-0.48%)

LLY Eli Lilly
$131.30 /

-0.63 (-0.48%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.